Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study-Reference-Cited by-同舟云学术

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study

Published:2023-03 Issue:3 Volume:29 Page:274-280
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Nishikubo Masashi^ORCID,Shimomura Yoshimitsu,Maruoka Hayato,Nasu Seiko,Nishioka Tomomi,Sakizono Kenji,Mitsuyuki Satoshi,Kubo Tomoyo,Okada Naoki,Nakagawa Daishi,Kamijo Kimimori,Imoto Hiroharu^ORCID,Yamamoto Ryusuke,Nagai Yuya,Hiramoto Nobuhiro,Yoshioka Satoshi^ORCID,Yonetani Noboru,Matsushita Akiko,Miyakoshi Chisato,Doi Asako,Ishikawa Takayuki

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference26 articles.

1. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study [published correction appears in Lancet Haematol;Sharma;Lancet Haematol,2021

2. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7);Cordonnier;Lancet Infect Dis,2019

3. Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: an observational study;Nishikubo;Br J Haematol,2022

4. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report;Jagasia;Biol Blood Marrow Transplant,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10

2. Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis;Blood Advances;2023-09-18

3. The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors;Acta Oncologica;2023-09-05

4. Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-Analysis Using GRADE;2023-08-13